• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

LIMR, the prototype of a novel family of endocytic receptors

LIMR, the prototype of a novel family of endocytic receptors

Bernhard Redl (ORCID: )
  • Grant DOI 10.55776/P17552
  • Funding program Principal Investigator Projects
  • Status ended
  • Start November 1, 2004
  • End October 31, 2008
  • Funding amount € 170,138

Disciplines

Biology (85%); Medical-Theoretical Sciences, Pharmacy (15%)

Keywords

    Lipocalin, Hydrophobic Ligands, Receptor, Protein-Protein Interaction, Endocytosis

Abstract Final report

All organisms have to deal with molecules which are hardly soluble in aqueous solutions. These include lipids, fatty acids, hormones and numerous other important signaling molecules, such as retinoids, pheromones or odorants. Therefore they have evolved a sophisticated transport system to handle these molecules. This system consists of several groups of specific transport proteins. One of them are lipocalins, a large family of small, mostly extracellular proteins which are able to bind and transport a large variety of hydrophobic molecules of all chemical classes. They are found in vertebrates and invertebrate animals, plants and bacteria. Lipocalins have been implicated in a number of important biological processes, including modulation of cell growth and metabolism, detoxification processes, inflammation, regulation of immune response, tissue development or animal behaviour. Whereas the structural basis of the interaction of lipocalins with their hydrophobic ligands is well understood now, there is a major lack of knowledge of the mechanisms by which lipocalins exert their biological effects, since there is only limited knowledge about lipocalin-specific cell receptors. We have recently identified and cloned the first authentic gene encoding a lipocalin receptor (LIMR) from human. Genome searching reveals that there is in fact a family of related genes, present in almost all higher organisms. We were able to demonstrate that this lipocalin- receptor acts as an endocytic receptor and is therefore the prototype of a novel family of receptors.. Therefore, this project is outlined to increase our knowledge of the molecular mechanism of a quite novel system widely used in a number of signaling and sensory processes in eukaryotes. Main topics of this project are to find out whether LIMR is a specific lipocalin receptor or a multifunctional receptor, able to bind a broad spectrum of protein ligands. We would also like to deduce the mechanism of ligand targeting within the cell and analyze proteins involved in this process. In addition, the ligand spectrum and function of the LIMR orthologous human Dif14 and mouse Limbr1 will be investigated. Since lipocalins are of significant interest in biotechnology as specific drug carriers or drug targeting and delivery system, our project on lipocalin receptors might also be of relevance for this particular field of research.

All organisms have to deal with molecules which are hardly soluble in aqueous solutions. These include lipids, fatty acids, hormones and numerous other important signaling molecules, such as retinoids, pheromones or odorants. Therefore they have evolved a sophisticated transport system to handle these molecules. This system consists of several groups of specific transport proteins. One of them are lipocalins, a large family of small, mostly extracellular proteins which are able to bind and transport a large variety of hydrophobic molecules of all chemical classes. They are found in vertebrates and invertebrate animals, plants and bacteria. Lipocalins have been implicated in a number of important biological processes, including modulation of cell growth and metabolism, detoxification processes, inflammation, regulation of immune response, tissue development or animal behaviour. Whereas the structural basis of the interaction of lipocalins with their hydrophobic ligands is well understood now, there is a major lack of knowledge of the mechanisms by which lipocalins exert their biological effects, since there is only limited knowledge about lipocalin-specific cell receptors. We have recently identified and cloned the first authentic gene encoding a lipocalin receptor (LIMR) from human. Genome searching reveals that there is in fact a family of related genes, present in almost all higher organisms. We were able to demonstrate that this lipocalin- receptor acts as an endocytic receptor and is therefore the prototype of a novel family of receptors.. Therefore, this project is outlined to increase our knowledge of the molecular mechanism of a quite novel system widely used in a number of signaling and sensory processes in eukaryotes. Main topics of this project are to find out whether LIMR is a specific lipocalin receptor or a multifunctional receptor, able to bind a broad spectrum of protein ligands. We would also like to deduce the mechanism of ligand targeting within the cell and analyze proteins involved in this process. In addition, the ligand spectrum and function of the LIMR orthologous human Dif14 and mouse Limbr1 will be investigated. Since lipocalins are of significant interest in biotechnology as specific drug carriers or drug targeting and delivery system, our project on lipocalin receptors might also be of relevance for this particular field of research.

Research institution(s)
  • Medizinische Universität Innsbruck - 100%

Research Output

  • 41 Citations
  • 1 Publications
Publications
  • 2007
    Title Lipocalin-interacting-membrane-receptor (LIMR) mediates cellular internalization of ß-lactoglobulin
    DOI 10.1016/j.bbamem.2007.10.010
    Type Journal Article
    Author Fluckinger M
    Journal Biochimica et Biophysica Acta (BBA) - Biomembranes
    Pages 342-347

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF